SRNESorrento Therapeutics Inc

$0.0009
$0.0006
(40.00%)
Today
Updated: 03:58 PM EDT
Mkt Cap$496,153.00
Vol230,137.00

About

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company's non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Sorrento Therapeutics Inc?
What is the 52-week high for Sorrento Therapeutics Inc?
What is Sorrento Therapeutics Inc stock price today?
What was Sorrento Therapeutics Inc stock price yesterday?
What is the 50-day moving average of Sorrento Therapeutics Inc?

Advertisement|Remove ads.